NPPA issued a notification regarding the fixation of the retail price of Teneligliptin Hydrobromide Hydrate IP Eq. to Teneligliptin IP 20 mg + Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg' for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer)

May 13, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on May 12, 2026, issued a notification regarding the fixation of the retail price of Teneligliptin Hydrobromide Hydrate IP Eq. to Teneligliptin IP 20 mg + Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg' for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer).

It states that the price for each fil-coated tablet containing: Teneligliptin Hydrobromide Hydrate IP Eq. to Teneligliptin IP 20 mg + Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg has been fixed at Rs. 10.17/- excluding GST.

[Notification no. - 19(5136)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT